We are live on ! Find out more
UBS AM

UBS AM Portfolio holdings

AUM $481B
1-Year Est. Return 26.39%
 

UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.

This Fund
S&P 500
This Quarter Est. Return
+3.91%
1 Year Est. Return
+26.39%
3 Year Est. Return
+93.76%
5 Year Est. Return
+124.47%
10 Year Est. Return
+503.98%
AUM
$473B
AUM Growth
+$12.4B
Cap. Flow
+$2.46B
Cap. Flow %
0.52%
Top 10 Hldgs %
35.78%
Holding
3,345
New
1,074
Increased
1,062
Reduced
1,120
Closed
60

Top Sells

Rank Stock Value
1
PLD icon
Prologis
PLD
+$1.33B
2
UNP icon
Union Pacific
UNP
+$1.2B
3
EQIX icon
Equinix
EQIX
+$929M
4
AVGO icon
Broadcom
AVGO
+$805M
5
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$685M

Sector Composition

Rank Sector Weight
1 Technology 37.43%
2 Financials 12.57%
3 Healthcare 10.57%
4 Consumer Discretionary 10.41%
5 Communication Services 9.95%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NLY icon
451
Annaly Capital Management
NLY
$17.4B
$121M 0.03%
5,425,766
+51,070
+1% +$1.11M
TMDX icon
452
Transmedics
TMDX
$2.91B
$121M 0.03%
996,878
-72,614
-7% -$9.11M
RPRX icon
453
Royalty Pharma
RPRX
$25.3B
$121M 0.03%
3,118,865
-11,071
-0.4% -$422K
BIO icon
454
Bio-Rad Laboratories Class A
BIO
$9.42B
$120M 0.03%
395,077
-2,094
-0.5% -$653K
FE icon
455
FirstEnergy
FE
$27.5B
$119M 0.03%
2,666,195
-177,136
-6% -$8.13M
BRO icon
456
Brown & Brown
BRO
$23.9B
$119M 0.03%
1,490,755
-39,014
-3% -$3.26M
RKLB icon
457
Rocket Lab Corp
RKLB
$51.8B
$119M 0.03%
1,701,885
+175,580
+12% +$10.1M
ROL icon
458
Rollins
ROL
$18.2B
$119M 0.03%
1,976,179
+147,596
+8% +$8.67M
CSL icon
459
Carlisle Companies
CSL
$15.4B
$117M 0.02%
366,508
-2,863
-0.8% -$928K
RS icon
460
Reliance Steel & Aluminium
RS
$21.6B
$117M 0.02%
404,155
-60,280
-13% -$16.9M
DD icon
461
DuPont de Nemours
DD
$19.2B
$117M 0.02%
967,979
-1,170,255
-55% -$132M
PPL
462
PPL Corp
PPL
$26.7B
$117M 0.02%
3,328,007
+49,078
+1% +$1.77M
LVS icon
463
Las Vegas Sands
LVS
$29.6B
$116M 0.02%
1,775,074
+20,013
+1% +$1.23M
AEE icon
464
Ameren
AEE
$30.1B
$115M 0.02%
1,154,008
-132,494
-10% -$13.6M
RRX icon
465
Regal Rexnord
RRX
$11.9B
$114M 0.02%
814,830
-371,536
-31% -$52.9M
JBHT icon
466
JB Hunt Transport Services
JBHT
$25.2B
$113M 0.02%
583,688
-25,750
-4% -$4.42M
VOYA icon
467
Voya Financial
VOYA
$9.19B
$113M 0.02%
1,520,193
+88,358
+6% +$6.44M
GPN icon
468
Global Payments
GPN
$22.8B
$112M 0.02%
1,447,809
-45,571
-3% -$3.67M
IP icon
469
International Paper
IP
$22B
$112M 0.02%
2,833,498
-121,553
-4% -$5M
AU icon
470
AngloGold Ashanti
AU
$48.7B
$111M 0.02%
1,303,835
-60,865
-4% -$4.75M
APG icon
471
APi Group
APG
$18B
$111M 0.02%
2,900,381
+37,049
+1% +$1.37M
LII icon
472
Lennox International
LII
$15.2B
$111M 0.02%
228,194
+1,416
+0.6% +$709K
DAL icon
473
Delta Air Lines
DAL
$60.1B
$110M 0.02%
1,584,611
-67,496
-4% -$4.22M
IONS icon
474
Ionis Pharmaceuticals
IONS
$9.4B
$110M 0.02%
1,388,567
+234,401
+20% +$17.6M
DRI icon
475
Darden Restaurants
DRI
$24.4B
$109M 0.02%
589,956
+16,647
+3% +$3.03M

Similar funds

UBS AM's Q4 2025 Portfolio in Review

As of Q4 2025, UBS AM held 3,345 positions worth $473B, up 2.7% from $461B the previous quarter. Its ten largest holdings account for 36% of the portfolio.

UBS AM's Q4 2025 filing shows 1,074 new, 1,062 increased, 1,120 reduced and 60 closed positions. Its largest new stake was Chubb: 2,548,307 shares worth $795M. The largest sale was Prologis, an estimated $1.33B.

By sector, the portfolio is most concentrated in Technology at 37% of assets, down from 38% a quarter earlier, followed by Financials and Healthcare.

  • UBS AM's largest Q4 2025 buy was Chubb: 2,548,307 shares worth $795M.
  • UBS AM added most to Spotify in Q4 2025, an estimated $727M increase.
  • UBS AM's biggest Q4 2025 reduction was Prologis, cutting an estimated $1.33B.
  • UBS AM fully exited Kellanova in Q4 2025, selling an estimated $211M.
  • UBS AM's ten largest holdings make up 36% of its $473B portfolio in Q4 2025.
  • UBS AM opened 1,074 new positions and closed 60 in Q4 2025.
  • UBS AM's portfolio value rose 2.7% quarter-over-quarter to $473B.

Based on UBS AM's 13F filing for Q4 2025, filed 13 Feb 2026.